Utilisation d'inhibiteurs de peptidiques perméables aux cellules de la voie de transduction de signal JNK pour le traitement des maladies digestives inflammatoires chroniques ou non chroniques

• 收藏
• 分享

专利权人:

Xigen S.A.

发明人:

申请号：

EP12001059.0

公开号：

EP2489362A1

申请日:

2009.06.02

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of non-chronic or chronic inflammatory digestive diseases, such as colitis, including e.g. Ulcerative colitis, Crohn's disease, diversion colitis, ischemic colitis, infectious colitis, fulminant colitis, chemical colitis, microscopic colitis, lymphocytic colitis, and atypical colitis, etc..

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/